The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaintel Regulatory News (MAI)

Share Price Information for Maintel (MAI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 250.00
Bid: 240.00
Ask: 260.00
Change: 0.00 (0.00%)
Spread: 20.00 (8.333%)
Open: 250.00
High: 250.00
Low: 250.00
Prev. Close: 250.00
MAI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

19 Jan 2023 15:33

RNS Number : 3156N
Maintel Holdings PLC
19 January 2023
 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR

Maintel Holdings Plc

("Maintel", the "Company" or the "Group")

Trading update for the 12-month period ended 31 December 2022

Maintel Holdings plc (the "Company", the "Group" or "Maintel") announces the following trading update for the financial year ended 31 December 2022 (FY22), based on unaudited financial information.

Group Revenue for the second half of FY22 is expected to be broadly in line with the first half of FY22, delivering approximately £91m of revenue for FY22. However, Adjusted EBITDA* has been negatively affected especially in the 4th Quarter, with Adjusted EBITDA for the year set to be above £4m, due to unexpected inflation costs on 3rd party vendor suppliers, professional services margin reduction due to project delays whilst having to maintain the associated cost base, increased office service costs and lower gross margin on technology sales.

Despite the challenging trading environment with global supply chain issues, a lower volume of public sector tenders and the economic downturn, the Group has built a total sales order backlog exceeding £45m of orders, all of which is under contract and with the project management teams in place for delivery, which will positively impact revenues and associated gross margin levels, especially on professional services in 2023 and beyond as the associated revenue is recognised.

The Company remained cash generative in the period and has reduced its net cash debt** position from £19.4m as at 31 December 2021 to £16.7m as at 31 December 2022, outperforming our expectations, despite Adjusted* EBITDA being below expected levels.

Maintel's transition to a cloud and managed services business continues apace with the Group nearing 170,000 contracted cloud seats at period end, up around 27% from 31 December 2021. The Group's cloud portfolio continues to be enhanced with both Public and Private cloud solutions, with enhanced offerings around Customer Experience.

Commenting on the Group's performance, Chief Executive Officer, Ioan MacRae, said:

"As the pandemic subsides, continuing global hardware supply chain disruptions and inflationary pressures have impacted 2022 performance despite resilient customer demand as evidenced by the sales order backlog standing at an all time high, guaranteeing increased revenue in 2023 and beyond. We have continued to invest in the development of the ICON cloud platform and further enhanced our wider product portfolio to continue to scale our business.  

In light of the disappointing second half EBITDA, the management team is in constructive conversations with its principal banking partner whilst implementing a program of revenue maximisation and process efficiency measures which not only recover Gross Margin performance after the economic headwinds of FY22, but also generate much improved EBITDA and cash generation which will recover to at least recent historical levels.

 

These actions, along with focused positioning of products and services into high growth market segments, support a return to growth in FY23. With the sales order book backlog unwind, continued cloud seat growth and c.73% of recurring revenue flowing into FY23, the Group has improved visibility of revenue generation, gross margin and faster re-alignment of overheads. This supports a substantially improved Adjusted EBITDA outlook for this financial year."

 

 *   Adjusted EBITDA is earnings before interest, tax, depreciation and amortisation, adjusted for share-based payments and exceptional costs.

** Net Cash Debt excludes IFRS16 lease liabilities

For further information please contact:

 

Maintel Holdings Plc

Ioan MacRae, Chief Executive Officer

Gab Pirona, Chief Financial Officer

Dan Davies, Chief Technology Officer

 

0344 871 1122

finnCap, (Nomad and Broker) Jonny Franklin-Adams / Emily Watts (Corporate Finance)

Sunila de Silva (Corporate Broking)

 

020 7220 0500

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFVELLIALIV
Date   Source Headline
2nd Sep 20197:00 amRNSInterim Results
30th Aug 20192:52 pmRNSDirector/PDMR Shareholding
30th Jul 20197:26 amRNSDirector/PDMR Shareholding
19th Jul 20191:00 pmRNSDirector Update, Director Shareholding and TVR
3rd Jun 20193:30 pmRNSNotification of Transactions of Directors
31st May 20198:00 amRNSDirector/PDMR Shareholding
20th May 20191:36 pmRNSDirector/PDMR Shareholding and Total Voting Rights
13th May 20194:26 pmRNSResult of AGM
3rd May 20197:00 amRNSBoard Change
1st May 20197:00 amRNSDirector/PDMR Shareholding
30th Apr 20194:16 pmRNSGrant of Options
10th Apr 20193:01 pmRNSNotice of AGM
1st Apr 201911:29 amRNSDirector/PDMR Shareholding
25th Mar 201910:00 amRNSDirector Dealing and Total Voting Rights
18th Mar 20197:00 amRNSFinal Results
4th Mar 20197:00 amRNSDirectorate Change
1st Mar 20199:49 amRNSDirector/PDMR Shareholding
30th Jan 20193:38 pmRNSDirector/PDMR Shareholding
28th Jan 20197:00 amRNSTrading Update and Notice of Results
4th Jan 20192:10 pmRNSDirector/PDMR Shareholding
3rd Dec 20183:17 pmRNSDirector/PDMR Shareholding
29th Nov 20184:23 pmRNSDirector/PDMR Shareholding
27th Nov 20181:50 pmRNSHolding(s) in Company
26th Nov 20183:16 pmRNSHolding(s) in Company
21st Nov 20187:00 amRNSTrading Update
31st Oct 20183:56 pmRNSResults of the Audit Tender Process
30th Oct 20181:20 pmRNSDirector/PDMR Shareholding
16th Oct 201810:59 amRNSDirector/PDMR Shareholding
2nd Oct 20184:57 pmRNSDirector/PDMR Shareholding
10th Sep 20187:00 amRNSInterim Results
28th Aug 20184:44 pmRNSDirector/PDMR Shareholding
30th Jul 20181:23 pmRNSDirector/PDMR Shareholding
20th Jul 201810:01 amRNSDirector/PDMR Shareholding
29th Jun 20187:00 amRNSAcquisition
28th Jun 20183:58 pmRNSDirector/PDMR Shareholding
29th May 20183:53 pmRNSDirector/PDMR Shareholding
18th May 20187:00 amRNSDirector/PDMR Shareholding
8th May 20183:14 pmRNSResult of AGM
30th Apr 20183:08 pmRNSDirector/PDMR Shareholding
12th Apr 20183:56 pmRNSGrant of Options
11th Apr 20183:49 pmRNSPosting of Annual Report & Notice of AGM
3rd Apr 20185:10 pmRNSDirector/PDMR Shareholding
19th Mar 20187:00 amRNSFinal Results
2nd Mar 20182:05 pmRNSDirector/PDMR Shareholding
2nd Feb 20187:00 amRNSTrading Update
30th Jan 20187:00 amRNSDirector/PDMR Shareholding
2nd Jan 20181:33 pmRNSDirector/PDMR Shareholding
6th Dec 20177:00 amRNSTrading Update
28th Nov 20173:29 pmRNSDirector/PDMR Shareholding
30th Oct 20179:20 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.